Resultados clínicos en receptores de trasplante renal posterior a la conversión a ImTOR

Autor: Lina M Rivera, Juan C. Gómez Vega, Juan Guillermo Posada Chávez, Liliana Mesa Ramirez, Luis A. Caicedo-Rusca, Oscar J. Serrano Ardila, Carlos Eduardo Durán Rebolledo, Jorge I. Villegas Otálora, Eliana Manzi Tarapues, Jessica Pino Escobar, Johanna Schweineberg López

Publikováno v: Revista Colombiana de Nefrología, Volume: 5, Issue: 1, Pages: 26-35, Published: JUN 2018
Revista Colombiana de Nefrología, Vol 5, Iss 1, Pp 26-35 (2018)

Introduction: mTOR inhibitors Sirolimus and Everolimus are an alternative for inmunosuppression in renal transplant recipients. The aim of the study was to describe the experience of patients with switch to mTOR inhibitors, followed up for more than

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8195511106f540e6da541cba01390b4
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S2500-50062018000100026&lng=en&tlng=en